Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

3 isobutyl 1 methylxanthine

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom, China, Sao Tome and Principe, Japan, France, Italy, Denmark, Macao, Canada, Spain, Austria, Australia, Switzerland, India, New Zealand, Belgium, Sweden, Mexico
About the product

3-isobutyl-1-methylxanthine is a chemical compound primarily used as a research tool in laboratories. It functions as a nonselective phosphodiesterase inhibitor, which can affect various cellular processes. The core function of this product is to serve as a laboratory reagent for scientific research purposes.

Automatically generated - may contain errors

Market Availability & Pricing

3-Isobutyl-1-methylxanthine (IBMX) is an active product commercially available through Merck Group's Sigma-Aldrich brand. The product is listed on their official website, indicating it is still in production.

Pricing for IBMX varies based on quantity and supplier. Sigma-Aldrich offers 100 mg for $58.70 and 1 g for $277.00. Other suppliers, such as Chem-Impex, list 250 mg at $65.40 and 1 g at $188.58. Please note that prices are subject to change and may vary by supplier and region.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

1 406 protocols using «3 isobutyl 1 methylxanthine»

1

Antidiabetic Compounds Screening Protocol

2025
Reagents and standards, including acarbose, acetonitrile, α-amylase, α-glucosidase, camphor, cinnamaldehyde, cinnamic acid, dexamethasone, dimethyl sulfoxide (DMSO), eugenol, formic acid, glucose, glutaMAX, insulin, 1-isobutyl-3- methylxanthine, methanol, menthol, p-nitrophenyl-α-D-glucopyranoside (PNPG), hydroxyethyl piperazine ethane sulfonic acid (HEPES), and resazurin sodium were bought from Sigma-Aldrich, USA. Glycyrrhizic acid monoammonium salt was obtained from Carlo Erba (Italy). Fetal bovine serum (FBS), Dulbecco's modified Eagle's medium (DMEM), antibiotic/antimycotic solution, Roswell Park Memorial Institute 1640 medium (RPMI 1640), 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA), and Qubit dsDNA broad range (BR) assay kits were obtained from Thermo Fisher Scientific, USA. A C-peptide 2 (Rat/Mouse) ELISA kit and phosphate-buffered saline solution (PBS) were bought from Merck-Millipore. A Glucose Uptake Assay kit (cell-Based) was acquired from Cayman Chemical (USA). The cell lines 3T3 J2 fibroblasts, 3T3-L1 fibroblasts, and RIN-m5F cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Murine Pre-adipocyte Differentiation Protocol

2025
3T3-L1 murine pre-adipocytes (CL-173; American Type Culture Collection, Manassas, VA, USA) were cultured and maintained according to the manufacturer’s instructions in Dulbecco’s modified Eagle’s medium (DMEM; HyClone, Logan, UT, USA) supplemented with 4 mM L-glutamine, 4500 mg/L glucose, 10% (v/v) low endotoxin sterile-filtered fetal bovine serum (FBS; Millipore-Sigma, Oakville, ON, Canada) and 1% (v/v) penicillin-streptomycin (Fisher Scientific, Mississauga, ON, Canada), as described previously [70 (link),83 (link)]. Pre-adipocytes were differentiated into adipocytes using DMEM containing 1 µmol/L dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 10 µg/mL insulin (all from Millipore-Sigma), and matured in DMEM supplemented with 10 µg/mL insulin, as described previously [70 (link),83 (link)]. Media were changed every two days. On day 8 post-differentiation, adipocytes were incubated for 12 h in serum-free DMEM containing 1% (v/v) penicillin-streptomycin prior to the addition of the experimental treatments.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Multilineage Differentiation Assay for iMSCs and BMSCs

2025
iMSCs and BMSCs were induced to differentiate into the adipogenic, chondrogenic, and osteogenic lineages for 21 days following our previously published protocol [25 (link)]. For adipogenesis, cells were plated in a 6-well plate at a density of 100,00 cells/cm² and induced by adipogenic medium consisting of high-glucose DMEM, 10% FBS, 1% antibiotics, 1 µM dexamethasone (Millipore Sigma), 0.5 mM 3-isobutyl-1-methylxanthine (Millipore Sigma), and 10 µg/ml insulin (Millipore Sigma), and 100 µM indomethacin (Sigma Aldrich). For chondrogenesis, 5 × 10⁵ iMSCs or BMSCs were collected and centrifuged at 600 x g for 5 min to form cell pellets. The pellets were then induced by chondrogenic medium consisting of high-glucose DMEM supplemented with 1% antibiotics, 1% ITS + Premix (Corning), 0.9 mM sodium pyruvate (Sigma Aldrich), L-ascorbic acid-2-phosphate (50 g/ml, Sigma Aldrich), L-proline (Sigma Aldrich), 0.1 µM dexamethasone (Sigma Aldrich), and transforming growth factor beta 1 (TGFB1) (10 ng/ml) (Thermo Fisher Scientific). For osteogenesis, cells were seeded in a 6-well plate at a density of 5 × 10³ cells/cm² and cultured with osteogenic medium containing low-glucose DMEM, 10% FBS, 1% antibiotics, 10 mM β-glycerophosphate (Sigma Aldrich), 50 µg/ml L-ascorbic acid-2-phosphate, and 0.1 µM dexamethasone. During the differentiation period, the induction medium was changed every 3 days.
After 21 days of differentiation, the cells were analyzed for mRNA expression of fat-, cartilage-, and bone-associated markers by qRT-PCR with primers listed in Table 1, histological staining, and biochemical assays. Cells induced for adipogenesis were fixed with 10% neutral buffered formalin and stained by Oil Red O (Millipore Sigma) to detect lipid droplets. The staining was imaged and then quantified by dissolving it in 100% isopropanol for the absorbance measurement at a wavelength of 515 nm to determine the lipid content. Cell pellets induced for chondrogenesis were fixed with 4% formaldehyde, dehydrated, infiltrated with xylene, and embedded in paraffin. The paraffin blocks were sectioned into 8-µm sections, deparaffinized, and stained with Alcian blue (Polysciences, Warrington, PA, USA) to detect proteoglycans. The quantification of glycosaminoglycan (GAG) was performed by digesting the cell pellets in papain solution and detected by the dimethylmethylene blue assay. The total GAG amount was normalized to the DNA content determined separately using the PicoGreen assay. For the analysis of osteogenesis, the cells were fixed with 60% isopropanol and stained by Alizarin Red S (Rowley Biochemical, Danvers, MA, USA) to detect calcium deposition. The calcium content was quantified by mixing the cells with 0.5 M hydrochloric acid (Sigma Aldrich) and measuring the mixture using the LiquiColor kit (Stanbio, Boerne, TX, USA) following the manufacturer’s instructions.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Characterization and Differentiation of hPDLSCs

2025
The third generation of hPDLSCs were characterised by fluorescence-activated cell sorting (FACS) analysis using a CytoFLEX (Beckman Coulter) with fluorescein isothiocyanate- or phycoerythrin-conjugated monoclonal antibodies against CD73, CD90, and CD45 (eBioscience). For osteogenic potential detection of hPDLSCs, the third generation of hPDLSCs were treated with pancreatin to make single cell suspension. The suspension was inoculated into a 6-well plate (2 × 105/well) and cultured with osteogenic induction medium consisting of α-MEM with 10% FBS (Gibco), 50 μg/mL ascorbic acid (Solarbio), 10 mmol/l β-glycerophosphate sodium (Solarbio), and 100 nmol/L dexamethasone (Solarbio). The osteogenic induction medium was refreshed every 3 days. After 14 days, the cells were stained with 2% Alizarin red S (Sigma Aldrich). For adipogenic potential detection of hPDLSCs, the 6-well plate inoculated with 2 × 105 hPDLSCs each well was cultured with the adipogenic induction medium consisting of α-MEM medium containing 10% FBS (Gibco), 1 µM dexamethasone (Solarbio), 0.5 mM 3-isobutyl-1-methylxanthine (Sigma Aldrich), and 10 μg/mL insulin (Solarbio). The adipogenic induction medium was refreshed every 3 days. After 14 days, the cells were stained with oil red O (Sigma Aldrich).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Isolation and Differentiation of Adipose Precursor Cells

2025
Four-week-old male C57BL/6 mice were sacrificed with carbon dioxide (CO2) inhalation followed by cervical dislocation. Adipose precursor cells were isolated from inguinal white adipose tissue and then homogenised in 5 mL of digestion buffer containing collagenase 1 (Worthington, LS004196), bovine serum albumin, and Dulbecco’s modified Eagle’s medium (DMEM) at 37 °C for 30 min. After homogenisation, the mixtures were filtered through a 100 μm cell strainer and centrifuged at 400 g for 5 minutes. The isolated cells were subsequently resuspended in a culture medium consisting of 10% foetal bovine serum (FBS, Corning) and 1% penicillin/streptomycin (Thermo Scientific) in DMEM (Corning). For differentiation to beige adipocytes, cells were exposed to beige differentiation induction medium containing 2 μg/mL dexamethasone, 0.5 mmol/L 3-isobutyl-1-methylxanthine, 125 μmol/L indomethacin, 5 μg/mL insulin, 1 μmol/L 3,3′,5-triiodo-L-thyronine, and 0.5 μmol/L rosiglitazone (all from Sigma-Aldrich). After two days, the cells were maintained in media without 3-isobutyl-1-methylxanthine, indomethacin, and dexamethasone from beige differentiation induction medium68 (link),69 . For white adipocyte differentiation, cells were exposed to a white differentiation induction medium containing 2 μg/mL dexamethasone, 0.5 mmol/L 3-isobutyl-1-methylxanthine, 5 μg/mL insulin, and 0.5 μmol/L rosiglitazone for 2 days. Then, differentiated cells were maintained in a medium containing 5 μg/mL insulin. Beige and white maintenance media were replaced every two days. 3T3-L1 cells were cultured in a medium comprising DMEM with 10% calf serum (Hyclone) and 1% penicillin/streptomycin. These cells underwent the same differentiation induction mentioned earlier for beige-like differentiation. Beige-like differentiated cells were maintained in differentiation media without indomethacin and dexamethasone from the beige differentiation induction media. Media were changed every two days70 (link),71 (link). For chemical treatment, a chemical-containing medium was added to the cultured cells every two days until harvesting for analysis, unless otherwise indicated. To inhibit the mitochondrial translation, cells were treated with 200 μg/ml chloramphenicol for two days with daily changes of maintenance media. For measuring the glutamate/glutamine ratio and checking the adipogenic gene expression with qPCR, cells were treated with 1 mM methionine sulfoximine (Sigma-Aldrich, M5379) and 20 mM glutamate (Sigma-Aldrich, G1251) in maintenance media. To inhibit glutaminase, 3T3-L1 cells were treated with 20 μM BPTES (Sigma-Aldrich, SML0601). Adipocyte precursor cells were treated with white adipocyte differentiation media containing 0.02 μg/mL cytochalasin D (Sigma-Aldrich, C8273) to induce F-actin disassembly. For small interfering RNAs (siRNA)-mediated Glul knock-down (KD), siRNAs were purchased from BIONEER, and lipofectamine RNAiMAX (Thermo Scientific, 13778075) was used to transfect siRNA into the cells, according to the manufacturer’s protocol in a final siRNA concentration of 100 nM. To evaluate the effect of Glul siRNA treatment on intracellular glutamate/glutamine ratio, a mixture of 3 different Glul siRNAs was transfected into precursor adipocyte cells twice. To confirm the impact of Glul KD on adipogenesis, preadipocytes were transfected by Glul siRNA for a day, harvested, and seeded to achieve an appropriate confluency of cells for differentiation. Next day, differentiation into beige adipocytes was induced. During differentiation, cells were transfected with Glul siRNA on days 1 and 3, and harvested on day 4. siRNA sequences were provided in Supplementary Data 8.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Top 5 protocols citing «3 isobutyl 1 methylxanthine»

1

Comprehensive Resource of Natural Compounds

A chemical library of 658-natural compounds was kindly provided by Dr. Sang Jeon Chung of Sungkyunkwan University (Suwon, Korea). Kaempferide (69545), dimethylsulfoxide (D2650), bafilomycin A1 (B1793), rapamycin (553210), tiliroside (79257), chloroquine (C6628), orlistat (O4139), palmitic acid (P5585), oleic acid (O1383), acridine orange (A6014), oil-red-O (O0625), dexamethasone (D8893), insulin (I0516), and 3-isobutyl-1-methylxanthine (I5879) were purchased from Sigma-Aldrich. BODIPY 493/503 (D3922), Hoechst33342 (H3570), lipofectamine LTX (94756), lipofectamine 2000 (52887), Plus reagent (10964), protease and phosphatase inhibitor solution (78441), M-PER kit (89842Y), DMEM, fetal bovine serum (FBS), bovine serum, and antibiotics were purchased from Invitrogen ThermoFisher Scientific. For in vivo experiments, Kaempferide (K0057) was purchased from TCI Chemicals. siRNA targeting TUFM was purchased from Dharmacon. mRFP-GFP-LC3B plasmids were kindly provided by Dr. Jaewhan Song of Yonsei University (Seoul, Korea).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Adipogenic Differentiation of ASCs

ASCs were seeded at a density of 10,000 cells/cm2 and grown till confluence in PM4 medium [47 (link)]. After a resting period of 48 hours in ASC medium (Dulbecco's modified Eagle medium/F-12 medium (1:1) with hydroxyethylpiperazineethanesulfonic acid and -glutamine (Gibco), supplemented with 33 μM biotin, 17 μM pantothenate, 12.5 μg/mL gentamicin), adipogenesis was induced using differentiation medium (ASC medium supplemented with 0.2nM insulin (Roche, Vienna, Austria), 0.5mM 3-isobutyl-1-methylxan-thine, 0.25 μM dexamethasone, 2.5% fetal bovine serum, and 10 μg/mL transferrin (Sigma, Vienna, Austria). After day 3 of differentiation, the medium was changed and the cells were cultivated in differentiation medium without 3-isobutyl-1-methylxanthine. For optical visualization of lipid droplets, cells were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) for 1 hour and stained with 0.3% Oil-Red-O (Sigma) in isopropanol/water (60:40) for 1 hour. Final washing procedure was carried out two times with H20.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Multilineage Differentiation Protocols for Nestin-Expressing Cells

Osteogenic differentiationNes-GFP+ cells were cultured in α-MEM (Invitrogen) containing 20% FBS, 100 μg/ml ascorbic acid (Sigma), 100 nM dexamethasone (Sigma), 10 mM β-glycerophosphate (Sigma), and 100 IU/ml penicillin/streptomycin (Invitrogen). The cells were fed every third day and maintained in culture for 4 weeks. The osteogenic-differentiated cells were fixed and stained with Alizarin red S to detect the presence of calcium, as previously described47 (link).
Adipogenic differentiation Adipogenic differentiation was induced by culturing cells in high-glucose DMEM supplemented with 100 nM dexamethasone (Sigma), 10 μg/ml insulin (Sigma), 0.2 mM indomethacin (Sigma), 0.5 mM 3-isobutyl-1-methylxanthine (Sigma), 10% FBS and 100 IU/ml penicillin-streptomycin. The cells were maintained in culture for 4 weeks and were fed every third day. The adipogenic-differentiated cells were confirmed by Oil red O staining, as described previously47 (link).
Chondrogenic differentiation Chondrogenic differentiation was induced using a cell pellet culture system as previously described48 (link). In brief, the Nes-GFP+ cells were suspended in a 15 ml conical tube containing 2 ml of induction medium consisting of DMEM (Invitrogen) with 3% FBS, 10 ng/ml tumor growth factor (TGF)-β3 (PeproTech), 1× ITS (Sigma), and 1 mM pyruvate (Sigma). The cells were fed every third day for 4 weeks, and the chondrocytes were identified by toluidine blue (Sigma) staining, as described previously49 (link).
Neurogenic differentiation Neural differentiation of the Nes-GFP+ cells was induced by plating cells onto poly-D-lysine/laminin-coated 24-well plates in N2B27 medium containing 10 ng/ml brain-derived neurotrophic factor and 10 ng/ml neurotrophin-3 (PeproTech), and the cells were maintained for 2 weeks. For astroglial differentiation, the Nes-GFP+ cells were exposed to 1% FBS and bone morphogenic protein (BMP)-4 (10 ng/ml; PeproTech) in N2B27 medium for 7 days50 (link). At each experimental endpoint, the differentiated cells were identified by immunostaining using the Tuj-1 and GFAP antibodies shown in Supplementary information, Table S2, or total RNA was extracted for RT-PCR analysis.
LC differentiation For LC lineage differentiation, the Nes-GFP+ cells were replated in fresh differentiation-inducing medium containing phenol red-free DMEM/F12, 2% FCS, 10 ng/ml PDGF-BB (PeproTech), 1 ng/ml LH (PeproTech), 1 nM thyroid hormone (PeproTech), 70 ng/ml insulin-like growth factor 1 (IGF1, PeproTech), and ITS supplement (Sigma), and they were incubated for 7 days, as previously described9 (link). Differentiation was subsequently confirmed by RT-PCR and immunostaining for LC lineage markers (antibodies shown in Supplementary information, Table S2).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Osteogenic and Adipogenic Differentiation

Primary bone marrow-derived cells were induced to osteogenesis in the standard osteogenic medium composed by α-MEM 10% FCS supplemented with 50 μg/ml ascorbic acid (Sigma-Aldrich Corporation, St Quentin Fallavier, France) and 10 mM β-glycerophosphate (Sigma-Aldrich corporation) for up to 14 days and the medium was changed every 2 or 3 days.
Adipogenesis was induced in the standard adipogenic medium containing Dulbecco’s Modified Eagle Medium (DMEM) (PAN Biotech) 10% FCS supplemented with 10 μg/ml insulin/0,1 or 0,5 μM dexamethasone (depending on the experiment)/100 μM indomethacin/500 μM 3-isobutyl-1-methylxanthine (Sigma-Aldrich Corporation) for 4 days and then maintained in 10 μg/ml insulin/0,1 or 0,5 μM dexamethasone/5 μM pioglitazone (Sigma-Aldrich Corporation) for 10 days and the medium was changed every 2 or 3 days.
In order to obtain both adipocytes and osteoblasts in the same differentiation medium, cells were cultured in the standard osteogenic medium supplemented with different concentrations of Dex ranging from 50 nM to 150 nM. For these experiments, co-differentiation medium referred to osteogenic medium added with 100 nM of Dex.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Trilineage Differentiation of Mesenchymal Stem Cells

Trilineage differentiation (AT-MSC, n = 6; BM-MSC, n = 4) was performed as previously described except where indicated [18 ]. Briefly, for adipogenesis and osteogenesis, cells were cultured for 14 days with either EM as described above or induction medium. Adipogenesis induction medium consisted of low-glucose DMEM with 1 μM dexamethasone (Sigma-Aldrich, St. Louis,Missouri), 0.5 mM 3-isobutyl-1-methyl-xanthine (Sigma-Aldrich, St. Louis, Missouri), 10 μg/mL recombinant human (rh) insulin (Sigma-Aldrich, St. Louis, Missouri), 0.2 mM indomethacin (Sigma-Aldrich, St. Louis, Missouri), 15% rabbit serum (Sigma-Aldrich, St. Louis, Missouri), 1% L-glutamine, and 1% antibiotic antimycotic solution (ABAM, Sigma-Aldrich, St. Louis, Missouri). Osteogenesis induction medium consisted of low-glucose DMEM with 0.1 μM dexamethasone, 10 mM glycerol 2-phosphate, 0.05 mM ascorbic acid, 10% FBS, 1% L-glutamine, and 1% ABAM. For chondrogenesis, 250,000 cells were pelleted in a 96-well plate and cultured for 21 days in high-glucose DMEM (Lonza, Walkersville, Maryland), 0.1 μM dexamethasone, 0.1 mg/mL ascorbic acid (Sigma-Aldrich, St. Louis, Missouri), 10 ng/mL TGF-β3 (R&D Systems, Minneapolis, Minnesota), 200 mM Glutamax (Life Technologies, Grand Island, New York), 10 mg proline (Sigma-Aldrich, St. Louis, Missouri), 40 μg/mL ascorbic acid, 100 mM sodium pyruvate (Life Technologies, Grand Island, New York), 1% Insulin-Transferrin-Selenium (Life Technologies, Grand Island, New York), 1% L-glutamine, and 1% ABAM. To promote better chondrogenesis, 0, 50, 100, or 200 ng/mL bone morphogenic protein 2 (BMP-2) was added to the media.
Adipogenesis and osteogenesis samples were stained with Oil Red O and Alizarin Red S stains (Sigma-Aldrich, St. Louis, Missouri) respectively. Chondrogenesis samples were histologically evaluated with toluidine blue staining for glycosaminoglycan content and hematoxylin and eosin staining for general pellet structure as previously reported [36 (link)]. Adipogenic, osteogenic, and chondrogenic mRNA transcript abundance was analyzed by RT-qPCR using the primers listed in Table 2. cDNA was synthesized from 500 ng RNA using the High Capacity cDNA Reverse Transcription Kit (Life Technologies, Grand Island, New York) using manufacturers' instructions. PCR reactions were performed using the PerfeCta SYBR Green FastMix, ROX (Quanta BioScience, Gaithersburg, Maryland) with the Applied Biosystems 7300 Real Time PCR system. Data were analyzed using the 2-ΔΔCT method. Gene expression data is presented as the induction medium-treated cultures relative to the expansion medium-treated control cultures with GAPDH used as reference gene.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.